These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 3910421)

  • 1. Postlabeling methods for carcinogen-DNA adduct analysis.
    Randerath K; Randerath E; Agrawal HP; Gupta RC; Schurdak ME; Reddy MV
    Environ Health Perspect; 1985 Oct; 62():57-65. PubMed ID: 3910421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical (postlabelling) methods for analysis of carcinogen-DNA adducts.
    Randerath K; Randerath E; Agrawal HP; Reddy MV
    IARC Sci Publ; 1984; (59):217-31. PubMed ID: 6443609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 32P-postlabeling test for covalent DNA binding of chemicals in vivo: application to a variety of aromatic carcinogens and methylating agents.
    Reddy MV; Gupta RC; Randerath E; Randerath K
    Carcinogenesis; 1984 Feb; 5(2):231-43. PubMed ID: 6697441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 32P-postlabeling assay for carcinogen-DNA adducts and other dna modifications.
    Randerath K; Randerath E
    J UOEH; 1989 Mar; 11 Suppl():368-86. PubMed ID: 2664950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the 32P-postlabelling assay to study transplacental carcinogens and transplacental carcinogenesis.
    Randerath K; Liehr JG; Gladek A; Randerath E
    IARC Sci Publ; 1989; (96):189-205. PubMed ID: 2509347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclease P1-mediated enhancement of sensitivity of 32P-postlabeling test for structurally diverse DNA adducts.
    Reddy MV; Randerath K
    Carcinogenesis; 1986 Sep; 7(9):1543-51. PubMed ID: 3017601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 32P-postlabeling analysis of non-radioactive aromatic carcinogen--DNA adducts.
    Gupta RC; Reddy MV; Randerath K
    Carcinogenesis; 1982; 3(9):1081-92. PubMed ID: 7139866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced sensitivity of 32P-postlabeling analysis of aromatic carcinogen:DNA adducts.
    Gupta RC
    Cancer Res; 1985 Nov; 45(11 Pt 2):5656-62. PubMed ID: 4053037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring carcinogen actions on DNA by 32P-postlabeling.
    Randerath K; Randerath E
    Princess Takamatsu Symp; 1990; 21():317-28. PubMed ID: 2134685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoranthene-DNA adducts: identification and quantification by an HPLC-32P-postlabeling method.
    Gorelick NJ; Wogan GN
    Carcinogenesis; 1989 Sep; 10(9):1567-77. PubMed ID: 2670301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 32P-labeling test for DNA damage.
    Randerath K; Reddy MV; Gupta RC
    Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6126-9. PubMed ID: 7031643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 32P-postlabeling assay for carcinogen-DNA adducts: nuclease P1-mediated enhancement of its sensitivity and applications.
    Reddy MV; Randerath K
    Environ Health Perspect; 1987 Dec; 76():41-7. PubMed ID: 2834194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new sensitive 32P-postlabeling assay based on the specific enzymatic conversion of bulky DNA lesions to radiolabeled dinucleotides and nucleoside 5'-monophosphates.
    Randerath K; Randerath E; Danna TF; van Golen L; Putman KL
    Carcinogenesis; 1989 Jul; 10(7):1231-9. PubMed ID: 2544310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 32P-post-labelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally-occurring alkenylbenzenes. I. Adult female CD-1 mice.
    Randerath K; Haglund RE; Phillips DH; Reddy MV
    Carcinogenesis; 1984 Dec; 5(12):1613-22. PubMed ID: 6499112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation and persistence of sterigmatocystin--DNA adducts in rat liver determined via 32P-postlabeling analysis.
    Reddy MV; Irvin TR; Randerath K
    Mutat Res; 1985 Oct; 152(1):85-96. PubMed ID: 4047087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-performance liquid chromatographic analysis of 32P-postlabeled DNA-aromatic carcinogen adducts.
    Levy GN; Weber WW
    Anal Biochem; 1988 Nov; 174(2):381-92. PubMed ID: 3239743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 32P-postlabeling assay in mice of transplacental DNA damage induced by the environmental carcinogens safrole, 4-aminobiphenyl, and benzo(a)pyrene.
    Lu LJ; Disher RM; Reddy MV; Randerath K
    Cancer Res; 1986 Jun; 46(6):3046-54. PubMed ID: 3698023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 32P-postlabeling analysis of DNA adduction in mice by synthetic metabolites of the environmental carcinogen, 7H-dibenzo[c,g]carbazole: chromatographic evidence for 3-hydroxy-7H-dibenzo[c,g]carbazole being a proximate genotoxicant in liver but not skin.
    Schurdak ME; Stong DB; Warshawsky D; Randerath K
    Carcinogenesis; 1987 Apr; 8(4):591-7. PubMed ID: 3829321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of 32P-postlabeling analysis of DNA from exfoliated oral mucosa cells as a means of monitoring exposure of the oral cavity to genotoxic agents.
    Foiles PG; Miglietta LM; Quart AM; Quart E; Kabat GC; Hecht SS
    Carcinogenesis; 1989 Aug; 10(8):1429-34. PubMed ID: 2502322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative 32P-analysis of cigarette smoke-induced DNA damage in human tissues and mouse skin.
    Randerath E; Avitts TA; Reddy MV; Miller RH; Everson RB; Randerath K
    Cancer Res; 1986 Nov; 46(11):5869-77. PubMed ID: 3756927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.